Sunshine Biopharma Discusses The Progress of Its COVID-19 and Anticancer Compounds with The Stock Day Podcast

Feb 17, 01:45 PM
The Stock Day Podcast welcomed Sunshine Biopharma (SBFM)(“the Company”), a company engaged in the development of Adva-27a, a unique anticancer compound, as well as the development of a treatment for COVID-19. CEO of the Company, Dr. Steve Slilaty, joined Stock Day host Everett Jolly.